entertainment -WSS

entertainment

author：leisure time 2025-09-06 05:03:22 - browse：153

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Bristol 'take

WSS

FDA authorizes Novavax’s updated Covid

FDA seeks to regulate lab

FDA authorizes Novavax’s updated Covid

WHO recommends dropping component of many flu vaccines

How the Dana

What to expect at HLTH 2023, the health care industry conference

Wikipedia

entertainment

hotspot

In Memoriam: Notable people who died in 2023

How one patient went off dialysis — and others can too

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

The high cost of giving birth even with insurance

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Jerome Adams on the need for new antivirals for Covid

WHO recommends dropping component of many flu vaccines

Dobbs anniversary: the lost opportunity of abortion as health care

Why Charlie Gard's case is so disturbing to Americans

focus

A virus, fished out of a lake, may have saved a man’s life

Medicare drug price negotiation program allowed for now

Stroke deaths set to near 10 million globally by 2050

Biogen shutters digital health group, ends Apple study, in cost cutting move

Paxlovid should be available without a positive Covid test

Medicaid, Medicare dual

leisure time

leisure time

entertainment

hotspot